Hints and tips:
Related Special Reports
...Carolyn Solan, head of external partnerships at consumer drugs group Haleon, which largely produces over-the-counter drugs that can be advertised more easily, said that “while partnering with expert patients...
...To be evaluated, companies must submit their products’ complete R&D documentation and code....
...Jean-Christophe Tortora, who leads CMA CGM’s media business, found the headline gave drugs dealers an unduly sympathetic voice....
...Patients with terminal breast cancer in England will miss out on a new drug already approved in Scotland, after spending watchdog NICE said Enhertu, developed by Japanese pharma company Daiichi Sankyo and...
...“NHS England expected drug companies AstraZeneca and Daiichi Sankyo to offer this treatment at a price that would enable Nice to recommend its use,” NHS England said....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...The Federal Trade Commission has sued to block US luxury goods group Tapestry’s $8.5bn acquisition of Capri Holdings, a move that threatens a bid to create a US rival to European giants LVMH and Kering....
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...The gene encodes the protein building blocks of a channel through which calcium metal ions flow inside nerve cells....
...Escobar Inc, a company set up by his brother Roberto, had filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) to register “Pablo Escobar” as a trademark for goods and...
...In recent years, the company has sought to diversify through acquisitions. It bought personal finance company Credit Karma for $8.1bn in 2020 and email marketing provider MailChimp for $12bn in 2021....
...SIG’s playbook is to bet small amounts of money on a lot of companies....
...Illumina said the company agreed “with the advocate general that the European Commission’s assertion of jurisdiction over this merger was improper”. Illumina bought Grail in 2021....
...Davis points to a long list of “more nimble” telehealth companies that also provide access to GLP-1 drugs, such as Noom, a direct-to-consumer weight-loss company with comparable subscription pricing to WW...
...The company sued the US government in 2020 when then-President Donald Trump issued an executive order to block the app from operating in the country, and gave ByteDance 90 days to divest from its American...
...That's pretty rare in business for a company to grow that much and change that little....
...The researchers developed a molecule known as a peptide — a building block of proteins — to weaken CRAB’s outer membrane....
...On Monday, the US Federal Trade Commission sued to block Tapestry’s $8.5bn acquisition of rival Capri Holdings. The pair are best known for their handbag brands....
...MainFT, last night: The Federal Trade Commission has sued to block US luxury goods group Tapestry’s $8.5bn acquisition of Capri Holdings, a move that threatens a bid to create a US rival to European giants...
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
...Another 50 cents is collected by the merchant acquirer, or companies such as Block or Stripe that provide the shop’s point-of-sale service system....
...Contributions from the company’s acquisitions — notably the $43bn purchase of cancer biotechnology company Seagen — have yet to move the needle....
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...But securing those bookings remains challenging, as blocks of hotel rooms previously set aside for Olympic delegations also come on the market....
...The technology also has considerable long-term potential to make novel substances at scale for drugs such as antibiotics, scientists said....
International Edition